Magnevist Solution For Injection 469.01Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Magnevist: Solution for injection (469.01mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

GADOPENTETATE DIMEGLUMINE (gad o PEN te tate) is a contrast agent. It is used to diagnose abnormalities during a MRI.

In-Depth Information

Magnevist 469.01mg/ml Solution for Injection

NDC: 504190188
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Magnetic Resonance Imaging (MRI)

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Do not freeze
Discard unused portion. Do not store for later use.
Magnevist 469.01mg/ml Solution for Injection

Reported Side Effects for Magnevist 469.01mg/ml Solution for Injection

Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Double Vision Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Secretion Of Tears Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Ear Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Skin Necrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Throat Irritation Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Tissue Death Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Tooth Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Excessive Sweating Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Extra Saliva Production Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Sneezing Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Eye Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fast Eye Movements Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Lightheadedness Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
2.3%*
Severity: MILD
Onset: RAPID
Upset Stomach Incidence:
2.7%*
Severity: MILD
Onset: EARLY
Headache Incidence:
4.8%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Magnevist

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5